Lionco Pharmaceutical Group Co., Ltd. Class ASSE: 603669

Announcement on Follow-up Rating Results of "Lionco Convertible Bonds" in 2026

· Issued by Lionco Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Follow-up Rating Results of "Lionco Convertible Bonds" in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis

Earlier from Lionco Pharmaceutical Group Co., Ltd. Class A

All Lionco Pharmaceutical Group Co., Ltd. Class A news releases